Ahn-Gook Pharmaceutical Co. Ltd (001540) — Capital Reinvestment Ratio
Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩14.44 Billion) in capital expenditures (₩2.76 Billion). Check 001540 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ahn-Gook Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Ahn-Gook Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Ahn-Gook Pharmaceutical Co. Ltd (001540) cash flow conversion.
Annual Capital Reinvestment Ratio for Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Ahn-Gook Pharmaceutical Co. Ltd from 2012 to 2024. See 001540 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 15.44x | ₩4.91 Billion | ₩75.89 Billion | ▲ +842.3% |
| 2022 | 1.64x | ₩1.79 Billion | ₩2.93 Billion | ▼ -40.2% |
| 2021 | 2.74x | ₩1.47 Billion | ₩4.04 Billion | ▲ +27.2% |
| 2020 | 2.16x | ₩11.19 Billion | ₩24.12 Billion | ▲ +1173.0% |
| 2019 | 0.17x | ₩22.08 Billion | ₩3.74 Billion | ▼ -38.3% |
| 2017 | 0.27x | ₩17.46 Billion | ₩4.79 Billion | ▼ -20.9% |
| 2016 | 0.35x | ₩12.62 Billion | ₩4.38 Billion | ▲ +184.5% |
| 2015 | 0.12x | ₩19.11 Billion | ₩2.33 Billion | ▼ -97.8% |
| 2014 | 5.56x | ₩1.29 Billion | ₩7.16 Billion | ▲ +207.2% |
| 2013 | 1.81x | ₩3.64 Billion | ₩6.60 Billion | ▲ +708.3% |
| 2012 | 0.22x | ₩11.51 Billion | ₩2.58 Billion | — |